Abstract
A crucial cause of the decreased bioactivity of nitric oxide (NO) in cardiovascular diseases is the uncoupling of the endothelial NO synthase (eNOS) caused by the oxidative stress-mediated deficiency of the NOS cofactor tetrahydrobiopterin (BH4). The reversal of eNOS uncoupling might represent a novel therapeutic approach. The treatment of apolipoprotein E knockout (ApoE-KO) mice with resveratrol resulted in the up-regulation of superoxide dismutase (SOD) isoforms (SOD1–SOD3), glutathione peroxidase 1 (GPx1), and catalase and the down-regulation of NADPH oxidases NOX2 and NOX4 in the hearts of ApoE-KO mice. This was associated with reductions in superoxide, 3-nitrotyrosine, and malondialdehyde levels. In parallel, the cardiac expression of GTP cyclohydrolase 1 (GCH1), the rate-limiting enzyme in BH4 biosynthesis, was enhanced by resveratrol. This enhancement was accompanied by an elevation in BH4 levels. Superoxide production from ApoE-KO mice hearts was reduced by the NOS inhibitor l-NG-nitro-arginine methyl ester, indicating eNOS uncoupling in this pathological model. Resveratrol treatment resulted in a reversal of eNOS uncoupling. Treatment of human endothelial cells with resveratrol led to an up-regulation of SOD1, SOD2, SOD3, GPx1, catalase, and GCH1. Some of these effects were preventable with sirtinol, an inhibitor of the protein deacetylase sirtuin 1. In summary, resveratrol decreased superoxide production and enhanced the inactivation of reactive oxygen species. The resulting reduction in BH4 oxidation, together with the enhanced biosynthesis of BH4 by GCH1, probably was responsible for the reversal of eNOS uncoupling. This novel mechanism (reversal of eNOS uncoupling) might contribute to the protective effects of resveratrol.
Footnotes
This work was supported by the Deutsche Forschungsgemeinschaft [Grant LI-1042/1-1].
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
doi:10.1124/jpet.110.168724.
↵
The online version of this article (available at http://jpet.aspetjournals.org) contains supplemental material.
-
ABBREVIATIONS:
- NO
- nitric oxide
- eNOS
- endothelial NO synthase
- SOD
- superoxide dismutase
- ApoE-KO
- apolipoprotein E knockout
- BH2
- 7,8-dihydrobiopterin
- BH4
- tetrahydrobiopterin
- GCH1
- GTP cyclohydrolase 1
- HPLC
- high-performance liquid chromatography
- l-NAME
- l-NG-nitro-arginine methyl ester
- RT-PCR
- reverse transcription polymerase chain reaction
- ROS
- reactive oxygen species
- MDA
- malondialdehyde
- PBS
- phosphate-buffered saline
- GPx
- glutathione peroxidase
- NOX
- NADPH oxidase
- TBS
- Tris-buffered saline
- 2-HE
- 2-hydroxyethidium
- DHE
- dihydroethidium
- SIRT1
- sirtuin 1.
- Received March 29, 2010.
- Accepted June 28, 2010.
- Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|